Global Vaccines Market 2024-2028

Global Vaccines Market 2024-2028

The vaccines market is forecasted to grow by USD 56.39 bn during 2023-2028, accelerating at a CAGR of 13.83% during the forecast period. The report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased funding for vaccine development and new vaccine launches, need for novel vaccines for chronic infections, and increasing use of adjuvants in vaccines.

Technavio's vaccines market is segmented as below:

By Type

• Human vaccine
• Animal vaccine

By End-user

• Hospitals
• Clinics

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of nanoparticle vaccines as one of the prime reasons driving the vaccines market growth during the next few years. Also, increase in awareness of vaccine-preventable diseases among travelers and advancement in vaccine delivery system will lead to sizable demand in the market.

The report on the vaccines market covers the following areas:

• Vaccines market sizing
• Vaccines market forecast
• Vaccines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccines market vendors that include Astellas Pharma Inc., Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., Valneva SE, and AstraZeneca PLC. Also, the vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.